Skip to Main Content

Paper Details

Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer's Disease Patients.
J Alzheimers Dis
33
2017

Datasets

Release 1.2